Investing in late-stage clinical trials and manufacturing of product candidates for five major infectious diseases: a modelling study of the benefits and costs of investment in three middle-income countries

Authors: Marco Schäferhoff, Armand Zimmerman, Mohamed M Diab, Wenhui Mao, Vipul Chowdhary, Davinder Gill, Robert Karanja, Mziwandile Madikizela, Osondu Ogbuoji, Gavin Yamey

Published: 2022-06-14

DOI: 10.1016/s2214-109x(22)00206-6

Source: Full article

---

Abstract

No abstract found.